Journal articleCell Cycle2020
Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma.
- Journal
- Cell Cycle
- Published
- 18 May 2020
- Citations
- 18
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Myeloma Overexpressed (MYEOV) is closely related to cell growth and differentiation in many cancer types. However, the role of this protein-coding gene in pancreatic ductal adenocarcinoma (PDAC) has rarely been investigated. … Excerpt only: this text is the publisher’s. Read it in full at the source.